- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (09/02/2019)
- Gwreiddiol (a wnaed Fel)
Version Superseded: 31/12/2020
Point in time view as at 09/02/2019.
The Human Medicines Regulations 2012, SCHEDULE 3 is up to date with all changes known to be in force on or before 27 August 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
Regulation 21(1)
1.—(1) This paragraph applies to an application for a manufacturer's licence relating to the manufacture or assembly of medicinal products.U.K.
(2) The application must contain—
(a)the name and address of the applicant;
(b)the name and address of the person (if any) making the application on the applicant's behalf;
(c)the address of each of the premises where any operations to which the licence relates are to be carried out;
(d)the address of any premises not mentioned by virtue of paragraph (c) where—
(i)the applicant proposes to keep any living animals, from which a substance used in the production of the medicinal product to which the application relates is to be derived, or
(ii)materials of animal origin, from which a substance is to be derived as mentioned in sub-paragraph (i), are to be kept;
(e)the address of each of the premises where medicinal products are to be stored, or from which medicinal products are to be distributed;
(f)the name, address, qualifications and experience of the person (“S”) whose duty it will be to supervise the manufacturing or assembling operations, and the name and job title of the person to whom S reports;
(g)the name, address, qualifications and experience of the person with responsibility for quality control in relation to the medicinal products to be manufactured or assembled under the licence (and, if that responsibility is to be carried out by the holder of the marketing authorisation, Article 126a authorisation, certificate of registration or traditional herbal registration relating to the products, a statement of that fact);
(h)the name, address and qualifications of the person to be responsible for any animals kept as mentioned in sub-paragraph (d)(i);
(i)the name, address and qualifications of the person to be responsible for the culture of any living tissue for use in the manufacture of medicinal products;
(j)the name, address and qualifications of the qualified person.
(3) The application must also contain—
(a)the pharmaceutical form of each medicinal product to be manufactured or assembled;
(b)details of the manufacturing or assembling operations to which the licence is to relate, including a statement of whether they include—
(i)the manufacture of medicinal products, or
(ii)the assembly of medicinal products;
(c)a statement of whether the medicinal products are to be manufactured or assembled for the purpose of—
(i)being administered to human beings in that form, or
(ii)as an ingredient in the preparation of another medicinal product;
(d)a statement of the facilities and equipment available at each of the premises where medicinal products are to be stored, or from which medicinal products are to be distributed;
(e)a separate statement, in respect of each of the premises mentioned in the application, of—
(i)the manufacturing or assembling operations capable of being carried out at those premises, and the class of medicinal products to which those operations relate, and
(ii)the equipment available at those premises for carrying out each stage of those operations;
(f)a statement of the authority conferred on the person mentioned in sub-paragraph (2)(g) to reject unsatisfactory medicinal products;
(g)a description of the arrangements for the identification and storage of materials and ingredients before and during manufacture or assembly and for the storage of medicinal products after manufacture or assembly;
(h)a description of the arrangements, at each of the premises where the applicant proposes to store medicinal products, for ensuring, so far as practicable, the turn-over of stocks of medicinal products;
(i)a description of the arrangements for maintaining—
(i)production records, and
(ii)records of analytical and other tests used in the course of manufacture or assembly for ensuring compliance of materials used in manufacture, or of medicinal products, with the specification for such materials or medicinal products;
(j)a description of the arrangements for keeping reference samples of—
(i)materials used in the manufacture of medicinal products, and
(ii)medicinal products;
(k)where the application relates to an exempt advanced therapy medicinal product, an outline of the arrangements for maintaining records to allow product traceability containing sufficient detail to enable the linking of a product to the patient who received it and vice versa; and
(l)details of—
(i)any manufacturing operations, other than those to which the licence is to relate, carried on by the proposed licence holder on or near the premises mentioned in sub-paragraph (2)(c), and
(ii)the substances or articles to which those operations relate.
2.—(1) This paragraph applies to an application for a manufacturer's licence relating to the import from a state other than an EEA State of medicinal products.U.K.
(2) The application must contain—
(a)the name and address of the applicant;
(b)the name and address of the person (if any) making the application on the applicant's behalf;
(c)the name, pharmaceutical form, country of origin and marketing authorisation number of each imported medicinal product;
(d)the address of each set of premises where the importation operation is to take place;
(e)the address of each set of premises where any testing associated with the importation is to take place;
(f)the address of each set of premises where medicinal products are to be stored, or from which they are to be distributed;
(g)the name, address and qualifications of the qualified person; and
(h)the name, address, qualifications and experience of the person in charge of quality control.
(3) The application must also contain—
(a)details of the importation operations to which the licence is to relate;
(b)a statement of the facilities and equipment available at each set of premises where medicinal products are to be stored, or from which they are to be distributed;
(c)details of—
(i)any manufacturing of medicinal products carried on by the applicant on or near the premises mentioned in sub-paragraph (2)(d) to (f), and
(ii)the substances or articles manufactured or used in the manufacturing;
(d)a description of the arrangements for storage of the medicinal products after importation;
(e)a description of the arrangements at each set of premises for ensuring, so far as practicable, the turn-over of stocks of medicinal products;
(f)a description of the arrangements for maintaining—
(i)records of importation, and
(ii)records of analytical and other procedures applied in the course of importation; and
(g)a description of the arrangements for keeping reference samples of the medicinal products.
3.—(1) This paragraph applies to an application for a wholesale dealer's licence.U.K.
(2) The application must contain—
(a)the name and address of the applicant;
(b)the name and address of the person (if any) making the application on the applicant's behalf;
(c)the address of each of the premises where medicinal products are to be stored, or from which they are to be distributed; and
(d)the name, address and qualifications of the responsible person.
(3) The application must also contain—
(a)details of the distribution by way of wholesale dealing to which the licence is to relate;
(b)a statement of whether the medicinal products to which the distribution relates are the subject of—
(i)a marketing authorisation,
(ii)a certificate of registration,
(iii)a traditional herbal registration, or
(iv)an Article 126a authorisation;
(c)a statement of whether the medicinal products to which the distribution relates are—
(i)prescription only medicines,
(ii)pharmacy medicines, or
(iii)medicines subject to general sale;
(d)a statement of whether the medicinal products to which the distribution relates are—
(i)special medicinal products, or
(ii)sold or supplied pursuant to regulation 174 (supply in response to spread of pathogenic agents etc);
(e)a statement of whether the medicinal products dealt in under the licence are to be used—
(i)for administration to human beings, or
(ii)as ingredients in the preparation of medicinal products for administration to human beings;
(f)an indication of the range of medicinal products to be stored at each of the premises mentioned in the application;
(g)a statement of the facilities and equipment available at those premises for storing and distributing medicinal products;
(h)a description of the arrangements at those premises for ensuring, so far as practicable, the turn-over of stocks of medicinal products (whether by the maintenance of records or by other means);
(i)details of an emergency plan which satisfies the requirements of regulation 43(7)(b), and
(j)a description of the arrangements for keeping records relating to products received or dispatched.
(4) In sub-paragraph (2)(d) “the responsible person” means the person who is to have responsibility, in relation to wholesale distribution activity carried out under the licence, for—
(a)ensuring that any conditions subject to which the licence is granted are complied with; and
(b)ensuring the quality of medicinal products being handled by the holder of the licence is being maintained in accordance with the requirements of the marketing authorisations, Article 126a authorisations, certificates of registration or traditional herbal registrations applicable to those products.
4.—(1) If an application does not include information or other matters required under this Schedule, the application must state—U.K.
(a)why that information is not applicable; or
(b)any other reason for not including them.
(2) An application for a licence must be in English.
(3) The pages of an application for a licence must be serially numbered.
(4) The applicant must sign the application.
(5) If the application is made by another person on behalf of the applicant, that person must also sign the application.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
Yr Offeryn Cyfan you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Yr Offeryn Cyfan heb Atodlenni you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys